Hunting Down Signal Transduction Antibodies

Chart 1 Chart 2 Chart 3 Chart 4 Chart 5 Within the last few years, research into signal transduction compounds and pathways has exploded, leading to a growing number of companies that sell antibodies for signal transduction. Whereas in the past, laboratories had to produce their own antibodies-or gain access to them through a network of contacts-dozens of companies now have commercially available signal transduction antibodies. This vast supply of antibodies has made it possible for researche

Written byShane Beck
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Within the last few years, research into signal transduction compounds and pathways has exploded, leading to a growing number of companies that sell antibodies for signal transduction. Whereas in the past, laboratories had to produce their own antibodies-or gain access to them through a network of contacts-dozens of companies now have commercially available signal transduction antibodies. This vast supply of antibodies has made it possible for researchers to pursue different proteins.

Targets of signal transduction antibodies can be broken down into various classes. For example, cell surface proteins and adhesion factors assist in mediating cellular communication, facilitating cell-cell binding, and regulating cellular migration and motility. Some of these include laminin, fibronectin, and integrin. Cell surface receptors, such as epidermal growth factor (EGF) receptor, estrogen receptor, and progesterone receptor, interact with growth factors to produce signaling cascades resulting in cell proliferation, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies